Stay updated on Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.5.5 has been added to the history, and the previous v3.5.4 entry has been removed. This reflects an update to the page's release notes in the history view.
    Difference
    0.1%
    Check dated 2026-06-05T00:06:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A new revision v3.5.4 has been added to the record history, replacing v3.5.3. This indicates an administrative update to the study record.
    Difference
    0.1%
    Check dated 2026-05-21T16:38:10.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    New revision entry v3.5.3 appears in the Record History, replacing the previous v3.5.2, indicating an updated submission to the study record. This is a metadata-level update rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-30T05:29:15.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.5.2 and removes the older v3.5.0 entry.
    Difference
    0.1%
    Check dated 2026-04-16T02:10:28.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the Record History and removed v3.4.3 from the history.
    Difference
    0.1%
    Check dated 2026-03-25T07:09:04.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the Record History. Revision v3.4.2 was removed.
    Difference
    0.2%
    Check dated 2026-03-10T15:34:51.000Z thumbnail image

Stay in the know with updates to Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.